$2.55T
Total marketcap
$182.75B
Total volume
BTC 50.08%     ETH 15.86%
Dominance

Maravai LifeSciences MRVI Stock

7.96 USD {{ price }} 3.376627% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
2B USD
LOW - HIGH [24H]
7.4 - 8.31 USD
VOLUME [24H]
3.04M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.9 USD

Maravai LifeSciences Price Chart

Maravai LifeSciences MRVI Financial and Trading Overview

Maravai LifeSciences stock price 7.96 USD
Previous Close 13.95 USD
Open 13.9 USD
Bid 0 USD x 2200
Ask 0 USD x 800
Day's Range 13.32 - 14.21 USD
52 Week Range 11.59 - 30.44 USD
Volume 1.98M USD
Avg. Volume 2.49M USD
Market Cap 3.36B USD
Beta (5Y Monthly) -0.231925
PE Ratio (TTM) 11.754386
EPS (TTM) -0.9 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 18.82 USD

MRVI Valuation Measures

Enterprise Value 2.19B USD
Trailing P/E 11.754386
Forward P/E 34.358974
PEG Ratio (5 yr expected) -1.5
Price/Sales (ttm) 4.6858263
Price/Book (mrq) 3.3864038
Enterprise Value/Revenue 3.058
Enterprise Value/EBITDA 5.033

Trading Information

Maravai LifeSciences Stock Price History

Beta (5Y Monthly) -0.231925
52-Week Change -49.69%
S&P500 52-Week Change 20.43%
52 Week High 30.44 USD
52 Week Low 11.59 USD
50-Day Moving Average 13.61 USD
200-Day Moving Average 15.63 USD

MRVI Share Statistics

Avg. Volume (3 month) 2.49M USD
Avg. Daily Volume (10-Days) 1.72M USD
Shares Outstanding 131.79M
Float 109.87M
Short Ratio 1.43
% Held by Insiders 0.56%
% Held by Institutions 98.13%
Shares Short 6.32M
Short % of Float 5.75%
Short % of Shares Outstanding 4.79%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 21.35%
Operating Margin (ttm) 56.10%
Gross Margin 77.34%
EBITDA Margin 60.74%

Management Effectiveness

Return on Assets (ttm) 11.54%
Return on Equity (ttm) 44.04%

Income Statement

Revenue (ttm) 717.73M USD
Revenue Per Share (ttm) 5.45 USD
Quarterly Revenue Growth (yoy) -67.70%
Gross Profit (ttm) 714.04M USD
EBITDA 435.98M USD
Net Income Avi to Common (ttm) 153.28M USD
Diluted EPS (ttm) 1.14
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 628.27M USD
Total Cash Per Share (mrq) 4.76 USD
Total Debt (mrq) 603.8M USD
Total Debt/Equity (mrq) 67.04 USD
Current Ratio (mrq) 6.129
Book Value Per Share (mrq) 3.957

Cash Flow Statement

Operating Cash Flow (ttm) 458.75M USD
Levered Free Cash Flow (ttm) 356.17M USD

Profile of Maravai LifeSciences

Country United States
State CA
City San Diego
Address 10770 Wateridge Circle
ZIP 92121
Phone 858 546 0004
Website https://www.maravai.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 650

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as plasmid DNA and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, Viral Clearance Prediction kits, and custom services. It serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.

Q&A For Maravai LifeSciences Stock

What is a current MRVI stock price?

Maravai LifeSciences MRVI stock price today per share is 7.96 USD.

How to purchase Maravai LifeSciences stock?

You can buy MRVI shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Maravai LifeSciences?

The stock symbol or ticker of Maravai LifeSciences is MRVI.

Which industry does the Maravai LifeSciences company belong to?

The Maravai LifeSciences industry is Biotechnology.

How many shares does Maravai LifeSciences have in circulation?

The max supply of Maravai LifeSciences shares is 251.4M.

What is Maravai LifeSciences Price to Earnings Ratio (PE Ratio)?

Maravai LifeSciences PE Ratio is now.

What was Maravai LifeSciences earnings per share over the trailing 12 months (TTM)?

Maravai LifeSciences EPS is -0.9 USD over the trailing 12 months.

Which sector does the Maravai LifeSciences company belong to?

The Maravai LifeSciences sector is Healthcare.

Maravai LifeSciences MRVI included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
NASDAQ Global Select Market Com NQGS 7837.41 USD
+0.85
7832.7 USD 7908.95 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD
Nasdaq US 700 Small Cap Index NQUS700SC 2078.81 USD
-0.4
2075.76 USD 2093.28 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2568.29 USD
+0.16
2566.7 USD 2581.47 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD